Minoxidil 5 mg oral versus Minoxidil 5 mg sublingual for treating Male Pattern Baldness
Not Applicable
- Conditions
- Androgenetic alopeciaC17.800.329.937
- Registration Number
- RBR-7wsgdm8
- Lead Sponsor
- Clinica Sanabria Transplante e Restauração Capilar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Male patients; age between 18 and 55 years; diagnosed with Androgenetic Alopecia classified on the Norwood Hamilton scale in 3V, 4V or 5V; clarified and agreeing to participate in the research, during consultations carried out at Clínica Sanabria
Exclusion Criteria
Patients who underwent previous treatment for hair loss in the last 4 months; hypertensive; heart disease; kidney disease; patients with other causes of hair loss or scalp dermatoses
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method